UPDATE : Monday, September 7, 2020
상단여백
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’ by Jeong Sae-im 2019-03-18 15:03
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data by Lee Han-soo 2019-03-18 14:23
Reimbursement for orphan drug Spinraza imminent by Kim Yun-mi 2019-03-18 12:02
Thea, OliX to cooperate in developing age-related macular degeneration treatment by Lee Han-soo 2019-03-18 12:02
Handok gets shares in TRIGR Therapeutics by Lee Han-soo 2019-03-18 12:02
라인
‘Low-dose chest CT can detect lung cancer for non-smokers’ by Lee Han-soo 2019-03-15 17:33
CHA Biotech revises separate operating profit to a loss in 2018 by Jeong Sae-im 2019-03-15 16:26
Korean patients lack knowledge about risk of resistance development by BTX by Lee Han-soo 2019-03-15 15:39
Dong-A ST slapped with ₩13.8 billion penalty for bribing doctors by Kwak Sung-sun 2019-03-15 15:38
Seoul to consider global trends in price talks of artificial blood vessels with Gore by Kwak Sung-sun 2019-03-15 15:38
라인
Theragen’s Lou Gehrig's disease treatment wins government support by Lee Han-soo 2019-03-15 13:21
Eoflow’s wearable artificial pancreas system recognized in US by Lee Han-soo 2019-03-15 13:20
'OliX to target global market with RNA technology' by Lee Han-soo 2019-03-15 11:44
SK Chemicals executive arrested for destroying evidence in humidifier sterilizers case by Jeong Sae-im 2019-03-15 11:41
[Special] Female doctors suffer discrimination from moment of selecting medical residents by Song Soo-youn 2019-03-15 10:24
라인
Idiopathic REM sleep behavior disorder raises risk of dementia, Parkinson’s by Lee Han-soo 2019-03-14 17:43
Loss-making Medipost seeks to avoid administrative issue designation by Jeong Sae-im 2019-03-14 14:33
KIMES 2019 opens 4-day show in Seoul by Lee Han-soo 2019-03-14 14:19
Key to successful dental implants for diabetic patients found by Lee Hye-seon 2019-03-14 11:18
Pharmbio Korea to develop antifungal drug with BioSynectics’ nanotechnology by Lee Han-soo 2019-03-13 17:48
여백
여백
여백
Back to Top